June 1, 2001 John Fiddes [address]Severance Agreement • August 14th, 2001 • Intrabiotics Pharmaceuticals Inc /De • Pharmaceutical preparations
This Letter Agreement (the “Letter Agreement”) is to inform you in advance that IntraBiotics Pharmaceuticals, Inc. (the “Company”) is restructuring its workforce at its facilities located at 2021 Stierlin Court, Mountain View, California and 1245 Terra Bella, Mountain View, California. This restructuring constitutes a “mass layoff” under the WARN Act.
June 21, 2001Collaborative Research and Technology Agreement • August 14th, 2001 • Intrabiotics Pharmaceuticals Inc /De • Pharmaceutical preparations
This letter (“Letter”) will serve to confirm the mutual release and termination of the Agreement between IntraBiotics and AMRI as reflected in your email of June 11, 2001. Capitalized terms contained in this Letter shall have the meaning set forth in the Agreement.
RELEASE AGREEMENTRelease Agreement • August 14th, 2001 • Intrabiotics Pharmaceuticals Inc /De • Pharmaceutical preparations • California
This Release Agreement (“Agreement”), dated and effective as of July 27, 2001 (the “Effective Date”), is by and between IntraBiotics Pharmaceuticals, Inc., a Delaware corporation, (“IntraBiotics”), and Diversa Corporation, a Delaware corporation (“Diversa,” and, together with IntraBiotics, the “Parties”). Defined terms used but not otherwise defined hereunder shall have the meanings given them in that certain Drug Discovery, Development, and License Agreement, dated as of January 6, 2001, between Diversa and IntraBiotics (“License Agreement”).
* ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. May 18,...License and Supply Agreement • August 14th, 2001 • Intrabiotics Pharmaceuticals Inc /De • Pharmaceutical preparations
Re: License and Supply Agreement between IntraBiotics Pharmaceuticals, Inc. (“IntraBiotics”) and Biosearch Italia, S.p.A. (“Biosearch”) dated as of May 8, 1998 (the “Agreement”)
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 14th, 2001 • Intrabiotics Pharmaceuticals Inc /De • Pharmaceutical preparations • California
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is entered into as of the 27th day of July, 2001 by and between INTRABIOTICS PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and DIVERSA CORPORATION, a Delaware corporation (the “Holder”).
FIRST AMENDMENT TO THE AGREEMENT BETWEEN INTRABIOTICS PHARMACEUTICALS, INC. AND ALBANY MOLECULAR RESEARCH, INC. FIRST AMENDMENT TO THE RESEARCH AND TECHNOLOGY AGREEMENT BETWEEN INTRABIOTICS PHARMACEUTICALS, INC. AND NEW CHEMICAL ENTITIES, INC.Research and Technology Agreement • August 14th, 2001 • Intrabiotics Pharmaceuticals Inc /De • Pharmaceutical preparations
THIS FIRST AMENDMENT TO THE RESEARCH AND TECHNOLOGY AGREEMENT is entered into as of the 13th day of April, 2001, (“Amendment Effective Date”) by and among INTRABIOTICS PHARMACEUTICALS, INC., a Delaware corporation (“INTRABIOTICS”) and ALBANY MOLECULAR RESEARCH, a Delaware corporation (“AMRI”).
